Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 31. October 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9627  Previews Next
   
   Articles 1 - 20 / 192523  
   
The evolving role of perioperative systemic therapy in bladder cancer.
Cancer
Atiq SO, Anker JF, Miller EJ, Karol AB, Mehrazin R, Sfakianos JP, Galsky MD.
PMID: 42963929 [PubMed - indexed for MEDLINE]


A multilevel intervention to improve adherence to prostate cancer active surveillance versus usual care: results from a pilot randomized controlled trial.
BMC Cancer
Chen JC, Skolarus TA, Furgal A, Rankin A, Wallner LP, Borza T, Hawley ST, Radhakrishnan A.
PMID: 42963760 [PubMed - indexed for MEDLINE]


PSMA Biology Through the Clinical Lens: Implications for Radioligand Therapy of Prostate Cancer with [(177)Lu]Lu-PSMA-617.
Drugs
Del Re M, Bauckneht M, Danesi R.
PMID: 42963536 [PubMed - as supplied by publisher]


CT-based multimodal fusion model for preoperative clear cell renal cell carcinoma grading: A multicenter study.
Eur J Radiol
Wu Y, Wang H, Liu C, Liu M, Yi H, Yu N, Jin B.
PMID: 42962514 [PubMed - as supplied by publisher]


Integrated single-cell and bulk RNA-Seq analysis reveals a LCR-related prognostic signature for precision prognostication and therapeutic stratification in clear cell renal cell carcinoma.
Cancer Treat Res Commun
Zhong W, Rao R, Zhang J, Cheng M, Wu X.
PMID: 42962510 [PubMed - as supplied by publisher]


Comprehensive Characterization of Crotonylation-Related Long Non-Coding RNAs Reveals a Prognostic Signature and Functional Landscape in Bladder Cancer.
J Environ Pathol Toxicol Oncol
Zhang W, Zheng K, Peng M, Zhang J, Wang X, Yuan Z.
PMID: 42962197 [PubMed - indexed for MEDLINE]


Prognostic value of the preoperative C-reactive protein-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma.
PLoS One
Qin M, Feng Z, Zhang C, Song W, Wang K, Chen Z.
PMID: 42961929 [PubMed - indexed for MEDLINE]


Reassessing the diagnostic value of spectral CT-derived parameters for pathological grading of urothelial carcinoma of the bladder.
Abdom Radiol (NY)
Wang X, Du S, Hu J, Liu X, Wen Z, Lin F.
PMID: 42961642 [PubMed - as supplied by publisher]


Malignant solitary fibrous tumour of the prostate with a concomitant prostatic adenocarcinoma - A case report and review of the literature.
Indian J Pathol Microbiol
Dhanasekaran V, Cima L.
PMID: 42961580 [PubMed - indexed for MEDLINE]


Histoplasma colonization of metastatic renal cell carcinoma (RCC) cells in a case of adrenal histoplasmosis involved by metastatic eosinophilic solid cystic RCC with rhabdoid differentiation.
Indian J Pathol Microbiol
Hota S, Chakrabarti S.
PMID: 42961577 [PubMed - indexed for MEDLINE]


PD-L1 Expression in muscle-invasive bladder carcinoma: correlation with tumor-stroma ratio and clinicopathological parameters.
Indian J Pathol Microbiol
Chaturvedi A, Nisam I, Mallya V, Mandal S, Singh CB.
PMID: 42961563 [PubMed - indexed for MEDLINE]


Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
J Oncol Pharm Pract
Cruz Castillo Y, Chen Liang A, Samperio VM, Bentley A, Roberts Trinidad EO, Codreanu I, Dasanu CA.
PMID: 42961340 [PubMed - as supplied by publisher]


Impact of the Multimodal Protocol on the Outcomes of Cancer Patients Undergoing Radical Cystectomy.
Rev Col Bras Cir
Petry MA, Polakowski CB, Rabito EI, Kool R, Luz M, Pereira JL, Sato BMK, Lombardi RG, Tomasich FDS.
PMID: 42961271 [PubMed - indexed for MEDLINE]


The current landscape of bladder-sparing therapies in BCG-refractory high-risk nonmuscle-invasive bladder cancer.
Curr Urol
Gu Y, He W, Yu X, Jiang C, Zhang Z, Xu C, Zeng S.
PMID: 42960368 [PubMed]


Explainable artificial intelligence in prostate and bladder cancer: A review of imaging, digital pathology, molecular profiling, and clinical data.
Curr Urol
Diamantidis D, Tsakaldimis G, Smyrlis N, Chousein C, Kafalis C, Foutzitzi K, Deligeorgiou E, Panagiotopoulos N, Lailisidis S, Georgellis C, Giannopoulos S, Giannakopoulos S, Kalaitzis C.
PMID: 42960345 [PubMed]


4Kscore as a Pre-MRI Reflex Test for Men with PSA 1.80-2.99 ng/ml in the Göteborg-2 Prostate Cancer Screening Trial.
Eur Urol Open Sci
Möller F, Josefsson A, Månsson M, Carlsson S, Lilja H, Spyratou V, Wallström J, Hugosson J, Arnsrud Godtman R.
PMID: 42960148 [PubMed]


Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions.
Curr Urol
Rival PM, Jiang J, Qu LG, O'Brien J, Gilmore P, Corcoran N.
PMID: 42960082 [PubMed]


Ultrasound with nerve stimulation versus ultrasound alone for obturator nerve block in transurethral resection of bladder tumor: A systematic review and meta-analysis.
Saudi J Anaesth
Hu Q, Gan L, Ouyang C, Peng L, Zhong C, Wang S.
PMID: 42960054 [PubMed]


Targeting lipid metabolism to overcome therapeutic resistance in renal cell carcinoma: Mechanisms and emerging strategies.
Curr Urol
Feng Y, Zhang S, Li J, Yue D, Wang Y.
PMID: 42960049 [PubMed]


ADAM19 Promotes EMT-Related Changes and Serves as a Prognostic Marker in Circulating Tumor Cells of Renal Cell Carcinoma.
Cancer Sci
He M, Li M, Ma Y, Chen Z, Guo L, Wang X, Wang W, Chong T, Wang Z.
PMID: 42958621 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 192523    Page 1 of 9627  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1